Search by Drug Name or NDC
NDC 50090-4534-00 HYLENEX Recombinant 150 [USP'U]/mL Details
HYLENEX Recombinant 150 [USP'U]/mL
HYLENEX Recombinant is a SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by A-S Medication Solutions. The primary component is HYALURONIDASE (HUMAN RECOMBINANT).
Product Information
| NDC | 50090-4534 |
|---|---|
| Product ID | 50090-4534_f8502d68-530a-4e10-880c-5a1ea20aa875 |
| Associated GPIs | 99350040102020 |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | HYLENEX Recombinant |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Hyaluronidase (Human Recombinant) |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | SUBCUTANEOUS |
| Active Ingredient Strength | 150 |
| Active Ingredient Units | [USP'U]/mL |
| Substance Name | HYALURONIDASE (HUMAN RECOMBINANT) |
| Labeler Name | A-S Medication Solutions |
| Pharmaceutical Class | Endoglycosidase [EPC], Glycoside Hydrolases [CS] |
| DEA Schedule | n/a |
| Marketing Category | BLA |
| Application Number | BLA021859 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 50090-4534-00 (50090453400)
| NDC Package Code | 50090-4534-0 |
|---|---|
| Billing NDC | 50090453400 |
| Package | 1 mL in 1 VIAL (50090-4534-0) |
| Marketing Start Date | 2019-09-18 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |